| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0167-8140(95)97448-M |
| P698 | PubMed publication ID | 7569011 |
| P2093 | author name string | Bartelink H | |
| Horiot JC | |||
| Bernier J | |||
| Pavy JJ | |||
| Bolla M | |||
| Denekamp J | |||
| Mornex F | |||
| Littbrand B | |||
| Gonzales-Gonzales D | |||
| Letschert J | |||
| P433 | issue | 1 | |
| P921 | main subject | toxicity | Q274160 |
| P304 | page(s) | 11-15 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | Radiotherapy and Oncology | Q14251029 |
| P1476 | title | EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. | |
| P478 | volume | 35 |
| Q59139029 | A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients |
| Q36616769 | A modified Inflammatory Bowel Disease questionnaire and the Vaizey Incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy |
| Q73677933 | Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial |
| Q35571229 | Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. |
| Q39227841 | Analysis and presentation. Clinical trials on prostate cancer |
| Q63366128 | Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial |
| Q35940177 | Axillary dissection in primary breast cancer: variations of the surgical technique and influence on morbidity |
| Q38628614 | CT-based quantitative evaluation of radiation-induced lung fibrosis: a study of interobserver and intraobserver variations |
| Q37287532 | Can cutaneous telangiectasiae as late normal-tissue injury predict cardiovascular disease in women receiving radiotherapy for breast cancer? |
| Q73980761 | Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters |
| Q73437176 | Carcinoma of the cervical stump: retrospective analysis of 77 cases |
| Q53061485 | Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy |
| Q34529177 | Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review |
| Q36786775 | Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience. |
| Q73812236 | Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment |
| Q40904688 | Complications following definitive irradiation for cancers of the oral cavity and the oropharynx (in a series of 1134 patients). |
| Q36166552 | Concurrent use of aromatase inhibitors and hypofractionated radiation therapy |
| Q48102044 | Cosmetic changes following surgery and accelerated partial breast irradiation using HDR interstitial brachytherapy : Evaluation by a multidisciplinary/multigender committee |
| Q33598555 | Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy |
| Q30454802 | Development, implementation, and compliance of treatment pathways in radiation medicine. |
| Q37393274 | Effectiveness of two different HDR brachytherapy regimens with the same BED value in cervical cancer |
| Q82697193 | Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients |
| Q42621722 | Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma |
| Q47924957 | Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma |
| Q73232504 | High dose rate Microselectron moulds for Kaposi sarcoma of the palate |
| Q92861954 | High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study |
| Q36534810 | Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial |
| Q24185851 | Hyperbaric oxygen therapy for late radiation tissue injury |
| Q24197835 | Hyperbaric oxygen therapy for late radiation tissue injury |
| Q24246614 | Hyperbaric oxygen therapy for late radiation tissue injury |
| Q24247339 | Hyperbaric oxygen therapy for late radiation tissue injury |
| Q73590010 | Hyperbaric oxygen therapy for late sequelae in women receiving radiation after breast-conserving surgery |
| Q33276001 | Hyperfractionated high-dose proton beam radiotherapy for clival chordomas after surgical removal. |
| Q77451501 | Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer |
| Q42045691 | Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer |
| Q35189570 | INTRAGO: intraoperative radiotherapy in glioblastoma multiforme—a phase I/II dose escalation study |
| Q33496347 | Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment |
| Q38825281 | In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study. |
| Q44328369 | Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scores |
| Q73739183 | Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients |
| Q50754518 | Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. |
| Q58229282 | Is there more than one late radiation proctitis syndrome? |
| Q33541467 | Lack of correlation between residual radiation-induced DNA damage, in keratinocytes assayed directly from skin, and late radiotherapy reactions in breast cancer patients. |
| Q74305863 | Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems |
| Q36706836 | Late rectal toxicity determined by dose-volume parameters in computed tomography-based brachytherapy for locally advanced cervical cancer |
| Q73367745 | Late skin and subcutaneous soft tissue changes after 10-Gy boost for breast conserving therapy |
| Q77308104 | Long-term results with radiotherapy for Stage I-II follicular lymphomas |
| Q34772278 | Low interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity scales: a survey of radiation oncologists. |
| Q79799201 | Management of biochemical failure following radical prostatectomy: salvage radiotherapy - a case series |
| Q36946726 | Measuring side effects after radiotherapy for pharynx cancer |
| Q33182058 | Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study |
| Q34757911 | Non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis. |
| Q94569835 | One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients |
| Q26471072 | Partial breast irradiation for early breast cancer |
| Q33184232 | Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors |
| Q30448386 | Patterns of failure after treatment of atypical meningioma with gamma knife radiosurgery |
| Q77839042 | Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone |
| Q34657706 | Polymorphisms in base excision repair genes: Breast cancer risk and individual radiosensitivity. |
| Q74574148 | Proposal of a new grading system for evaluation of tongue hemiatrophy as a late effect of brachytherapy for oral tongue cancer |
| Q36728871 | Prospective study validating inter- and intraobserver variability of tissue compliance meter in breast tissue of healthy volunteers: potential implications for patients with radiation-induced fibrosis of the breast |
| Q48660396 | Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl |
| Q35129087 | Quality assurance in radiotherapy |
| Q39653246 | Quantification of masticatory muscle atrophy after high-dose radiotherapy |
| Q38209448 | Quantifying fibrosis in head and neck cancer treatment: An overview. |
| Q47405770 | Radiobiological evaluation of breast cancer radiotherapy accounting for the effects of patient positioning and breathing in dose delivery. A meta analysis |
| Q42855209 | Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma |
| Q38010805 | Radiotherapy-induced hypopituitarism: a review |
| Q34640489 | Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study |
| Q36035250 | Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis |
| Q53407396 | Scoring of treatment-related late effects in prostate cancer. |
| Q42571229 | Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding |
| Q38671404 | Sexual Dysfunction in Females after Cancer Treatment: an Unresolved Issue |
| Q44264206 | Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and |
| Q73131151 | Solitary brain metastases treated with the Leksell gamma knife: prognostic factors for patients |
| Q34783514 | Studies on radiosensitivity from an epidemiological point of view - overview of methods and results |
| Q44447446 | Synchronous postoperative adjuvant chemoradiation therapy for locally advanced carcinoma of the rectum. |
| Q44781994 | T.i.d. accelerated radiotherapy alone or alternating with chemotherapy in patients with a locally advanced ORL cancer: analysis of late toxicity |
| Q46961215 | Target localization and toxicity in dose-escalated prostate radiotherapy with image-guided approach using daily planar kilovoltage imaging |
| Q36194609 | The Evolution of and Risk Factors for Neck Muscle Atrophy and Weakness in Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy: A Retrospective Study in an Endemic Area |
| Q35129094 | The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts |
| Q36610079 | The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes |
| Q33532886 | The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. |
| Q43933509 | Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancer |
| Q39430613 | Tissue compliance meter is a more reproducible method of measuring radiation-induced fibrosis than late effects of normal tissue-subjective objective management analytical in patients treated with intracavitary brachytherapy accelerated partial brea |
| Q47910173 | Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial |
| Q41715164 | Towards evidence based radiation oncology: improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. |
| Q35091194 | Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens |
| Q45832046 | Ultrasound-assisted endocavitary HDR-Ir(192) brachytherapy for unresectable locally advanced uterine cervix carcinoma: retrospective analysis focusing the efficacy and tolerability |
| Q84201965 | Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience |
| Q24193759 | Vaginal dilator therapy for women receiving pelvic radiotherapy |
| Q24235575 | Vaginal dilator therapy for women receiving pelvic radiotherapy |
| Q24242848 | Vaginal dilator therapy for women receiving pelvic radiotherapy |
| Q38631063 | Valid and reliable techniques for measuring fibrosis in patients with head and neck cancer postradiotherapy: A systematic review. |
| Q73247690 | [Radiation-induced superficial fibrosis and TGF-alpha 1] |
| Q74066422 | [Risk factors of late complications after interstitial 192Ir brachytherapy in cancers of the oral cavity] |
| Q74617387 | [Scoring system of late effects of radiations on normal tissues: the SOMA-LENT scale] |
Search more.